Bacillus anthracis Dissemination through Hosts

Bacillus anthracis and Anthrax

Volumn , Issue , 2010, Pages 227-249

  Glomski, Ian J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

"Trojan horse" model inhaled dormant spores entering alveoli, phagocytosed by alveolar macrophages; B. anthracis dissemination in host bacterium's ability, in avoiding destruction by host defenses; Bacillus anthracis dissemination through hosts oral ingestion of spores, in alimentary tract, primary route of infection in grazing herbivores

Indexed keywords

EID: 84888654096     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470891193.ch12     Document Type: Chapter

References (143)

1. Abergel, R. J., Wilson, M. K., Arceneaux, J. E. et al. 2006. Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A, 103, 18499 - 18503.
2. Abramova, F. A., Grinberg, L. M., Yampolskaya, O. V., and Walker, D. H. 1993. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A, 90, 2291 - 2294.
3. Agrawal, A., Lingappa, J., Leppla, S. H. et al. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature, 424, 329 - 334.
4. Amidi, S., Dutz, W., Kohout, E., and Ronaghy, A. 1974. Human anthrax in Iran. Report of 300 cases and review of literature. Tropenmed Parasitol, 25, 96 - 104.
5. Aronson, A. I., Bell, C., and Fulroth, B. 2005. Plasmid-encoded regulator of extracellular proteases in Bacillus anthracis. J Bacteriol, 187, 3133 - 3138.
6. Baillie, L., Hibbs, S., Tsai, P. et al. 2005. Role of superoxide in the germination of Bacillus anthracis endospores. FEMS Microbiol Lett, 245, 33 - 38.
7. Baldari, C. T., Tonello, F., Paccani, S. R., and Montecucco, C. 2006. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol, 27, 434 - 440.
8. Barth, H., Aktories, K., Popoff, M. R., and Stiles, B. G. 2004. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev, 68, 373 - 402.
9. Bearden, S. W., Fetherston, J. D., and Perry, R. D. 1997. Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect Immun, 65, 1659 - 1668.
10. Beatty, M. E., Ashford, D. A., Griffi n, P. M. et al. 2003. Gastrointestinal anthrax: review of the literature. Arch Intern Med, 163, 2527 - 2531.
11. Berthier, M., Fauchere, J. L., and Perrin, J. 1996. Fulminant meningitis due to Bacillus anthracis in 11-year-old girl during Ramadan. Lancet, 347, 828.
12. Bischof, T. S., Hahn, B. L., and Sohnle, P. G. 2007. Characteristics of spore germination in a mouse model of cutaneous anthrax. J Infect Dis, 195, 888 - 894.
13. Boyden, E. D. and Dietrich, W. F. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet, 38, 240 - 244.
14. Bozue, J., Cote, C. K., Moody, K. L., and Welkos, S. L. 2007a. Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis. Infect Immun, 75, 508 - 511.
15. Bozue, J., Moody, K. L., Cote, C. K. et al. 2007b. Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fi broblasts, and endothelial cells but not to macrophages. Infect Immun, 75, 4498 - 4505.
16. Bradley, K. A., Mogridge, J., Mourez, M. et al. 2001. Identifi cation of the cellular receptor for anthrax toxin. Nature, 414, 225 - 229.
17. Brahmbhatt, T. N., Janes, B. K., Stibitz, E. S. et al. 2007. Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity. Infect Immun, 75, 5233 - 5239.
18. Brittingham, K. C., Ruthel, G., Panchal, R. G. et al. 2005. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol, 174, 5545 - 5552.
19. Brookmeyer, R. and Blades, N. 2002. Prevention of inhalational anthrax in the U.S. outbreak. Science, 295, 1861.
20. Bullen, J. J., Rogers, H. J., Spalding, P. B., and Ward, C. G. 2006. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol, 55, 251 - 258.
21. Candela, T. and Fouet, A. 2005. Bacillus anthracis CapD, belonging to the gamma - glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol Microbiol, 57, 717 - 726.
22. CDC. 2008. Cutaneous anthrax associated with drum making using goat hides from West Africa - Connecticut, 2007. Morbidity and Mortality Weekly Report, 57, 628 - 631.
23. Cendrowski, S., Macarthur, W., and Hanna, P. 2004. Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence. Mol Microbiol, 51, 407 - 417.
24. Chung, M. C., Popova, T. G., Millis, B. A. et al. 2006. Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J Biol Chem, 281, 31408 - 31418.
25. Cleret, A., Quesnel-Hellmann, A., Vallon-Eberhard, A. et al. 2007. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol, 178, 7994 - 8001.
26. Cote, C. K., Rea, K. M., Norris, S. L. et al. 2004. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog, 37, 169 - 175.
27. Cote, C. K., Rossi, C. A., Kang, A. S. et al. 2005. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog, 38, 209 - 225.
28. Cote, C. K., Van Rooijen, N., and Welkos, S. L. 2006. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect Immun, 74, 469 - 480.
29. Cote, C. K., Dimezzo, T. L., Banks, D. J. et al. 2008. Early interactions between fully virulent Bacillus anthracis and macrophages that infl uence the balance between spore clearance and development of a lethal infection. Microbes Infect, 10, 613 - 619.
30. Cowan, G. J., Atkins, H. S., Johnson, L. K. et al. 2007. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Vaccine, 25, 7197 - 7205.
31. Crawford, M. A., Aylott, C. V., Bourdeau, R. W., and Bokoch, G. M. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol, 176, 7557 - 7565.
32. Cybulski, R. J. Jr., Sanz, P., Alem, F. et al. 2009. Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress. Infect Immun, 77, 274 - 285.
33. Dance, A. 2008. Silicon highlights remaining questions over anthrax investigation. Nature, doi:10.1038/ news.2008.1137.
34. Davies, J. C. 1983. A major epidemic of anthrax in Zimbabwe. Part II. Cent Afr J Med, 29, 8 - 12.
35. De Voss, J. J., Rutter, K., Schroeder, B. G. et al. 2000. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci U S A, 97, 1252 - 1257.
36. Dixon, T. C., Fadl, A. A., Koehler, T. M. et al. 2000. Early Bacillus anthracis - macrophage interactions: intracellular survival survival and escape. Cell Microbiol, 2, 453 - 463.
37. Druett, H. A., Henderson, D. W., Packman, L., and Peacock, S. 1953. Studies on respiratory infection. I: The infl uence of particle size on respiratory infection with anthrax spores. J Hyg (Lond), 51, 359 - 371.
38. Drysdale, M., Heninger, S., Hutt, J. et al. 2005. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J, 24, 221 - 227.
39. Duesbery, N., Woude, V., Webb, C., and Klimpel, K. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science, 280, 734 - 737.
40. Dutz, W., Saidi, F., and Kohout, E. 1970. Gastric anthrax with massive ascites. Gut, 11, 352 - 354.
41. Firoved, A. M., Miller, G. F., Moayeri, M. et al. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol, 167, 1309 - 1320.
42. Fisher, N. and Hanna, P. 2005. Characterization of Bacillus anthracis germinant receptors in vitro. J Bacteriol, 187, 8055 - 8062.
43. Friedlander, A. M. 1997. Anthrax. In Medical Aspects of Chemical and Biological Warfare, ed. R. Zajtchuk. Washington, DC: Offi ce of the Surgeon General.
44. Friedlander, A. M., Welkos, S. L., Pitt, M. L. et al. 1993. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis, 167, 1239 - 1243.
45. Fritz, D. L., Jaax, N. K., Lawrence, W. B. et al. 1995. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest, 73, 691 - 702.
46. Garner, B. L., Arceneaux, J. E, and Byers, B. R. 2004. Temperature control of a 3,4-dihydroxybenzoate (protocatechuate)-based siderophore in Bacillus anthracis. Curr Microbiol, 49, 89 - 94.
47. Gerhardt, P. 1967. Cytology of Bacillus anthracis. Fed Proc, 26, 1504 - 1517.
48. Gerhardt, P. and Ribi, E. 1964. Ultrastructure of the exosporium enveloping spores of Bacillus cereus. J Bacteriol, 88, 1774 - 1789.
49. Giorno, R., Bozue, J., Cote, C. et al. 2007. Morphogenesis of the Bacillus anthracis spore. J Bacteriol, 189, 691 - 705.
50. Gleiser, C. A., Berdjis, C. C., Hartman, H. A., and Gochenour, W. S. 1963. Pathology of experimental respiratory anthrax in Macaca mulatta. Br J Exp Pathol, 44, 416 - 426.
51. Glomski, I. J., Corre, J. P., Mock, M., and Goossens, P. L. 2007a. Noncapsulated toxinogenic Bacillus anthracis presents a specifi c growth and dissemination pattern in naive and protective antigen-immune mice. Infect Immun, 75, 4754 - 4761.
52. Glomski, I. J., Fritz, J. H., Keppler, S. J. et al. 2007b. Murine splenocytes produce infl ammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol, 9, 502 - 513.
53. Glomski, I. J., Piris-Gimenez, A., Huerre, M. et al. 2007c. Primary involvement of pharynx and Peyer ' s patch in inhalational and intestinal anthrax. PLoS Pathog, 3, e76.
54. Glomski, I. J., Dumetz, F., Jouvion, G. et al. 2008. Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specifi c organ targeting. Microbes Infect, 10, 1398 - 1404.
55. Guidi-Rontani, C. 2002. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol, 10, 405 - 409.
56. Guidi-Rontani, C., Weber-Levy, M., Labruyere, E., and Mock, M. 1999. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol, 31, 9 - 17.
57. Guidi-Rontani, C., Levy, M., Ohayon, H., and Mock, M. 2001. Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol, 42, 931 - 938.
58. Guillemin, J. 1999. Anthrax: The Investigation of a Deadly Outbreak. Berkeley: University of California Press.
59. Harper, G. J. and Morton, J. D. 1953. The respiratory retention of bacterial aerosols: experiments with radioactive spores. J Hyg (Lond), 51, 372 - 385.
60. Harvill, E. T., Lee, G., Grippe, V. K., and Merkel, T. J. 2005. Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect Immun, 73, 4420 - 4422.
61. Heffernan, B. J., Thomason, B., Herring-Palmer, A. et al. 2006. Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax. Infect Immun, 74, 3756 - 3764.
62. Heffernan, B. J., Thomason, B., Herring-Palmer, A., and Hanna, P. 2007. Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax. FEMS Microbiol Lett, 271, 98 - 105.
63. Henderson, D. W., Peacock, S., and Belton, F. C. 1956. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J Hyg (Lond), 54, 28 - 36.
64. Holmes, C. 2003. Spores, Plagues, and History: The Story of Anthrax. Dallas, TX: Durban House.
65. Hoover, D. L., Friedlander, A. M., Rogers, L. C. et al. 1994. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun, 62, 4432 - 4439.
66. Hu, H., Sa, Q., Koehler, T. M. et al. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol, 8, 1634 - 1642.
67. Hu, H., Emerson, J., and Aronson, A. I. 2007. Factors involved in the germination and inactivation of Bacillus anthracis spores in murine primary macrophages. FEMS Microbiol Lett, 272, 245 - 250.
68. Inglesby, T. V., O ' Toole, T., Henderson, D. A. et al. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA, 287, 2236 - 2252.
69. Ireland, J. A. and Hanna, P. C. 2002. Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS. Infect Immun, 70, 5870 - 5872.
70. Ivanova, N., Sorokin, A., Anderson, I. et al. 2003. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature, 423, 87 - 91.
71. Kang, T. J., Fenton, M. J., Weiner, M. A. et al. 2005. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect Immun, 73, 7495 - 7501.
72. Keim, P., Smith, K. L., Keys, C. et al. 2001. Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J Clin Microbiol, 39, 4566 - 4567.
73. Kern, J. W. and Schneewind, O. 2008. BslA, a pXO1-encoded adhesin of Bacillus anthracis. Mol Microbiol, 68, 504 - 515.
74. Kim, C., Wilcox-Adelman, S., Sano, Y. et al. 2008. Anti-infl ammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc Natl Acad Sci U S A, 105, 6150 - 6155.
75. Koch, R. 1876. Die Aetiologie der Milzbrand-Krankheit, begr ü ndet auf die Entwicklungsgeschichte des Bacillus Anthracis. B eiträ ge zur Biologie der Pfl anzen, 2, 277 - 311.
76. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A, 79, 3162 - 3166.
77. Lincoln, R. E., Hodges, D. R., Klein, F. et al. 1965. Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis, 115, 481 - 494.
78. Liu, H., Bergman, N. H., Thomason, B. et al. 2004. Formation and composition of the Bacillus anthracis endospore. J Bacteriol, 186, 164 - 178.
79. Loving, C. L., Khurana, T., Osorio, M. et al. 2009. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun, 77, 255 - 265.
80. Madden, J. C., Ruiz, N., and Caparon, M. 2001. Cytolysin-mediated translocation (CMT). A functional equivalent of Type III secretion in gram-positive bacteria. Cell, 104, 143 - 152.
81. Makino, S., Uchida, I., Terakado, N. et al. 1989. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J Bacteriol, 171, 722 - 730.
82. Makino, S., Watarai, M., Cheun, H. I. et al. 2002. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J Infect Dis, 186, 227 - 233.
83. Maresso, A. W., Chapa, T. J., and Schneewind, O. 2006. Surface protein IsdC and Sortase B are required for heme-iron scavenging of Bacillus anthracis. J Bacteriol, 188, 8145 - 8152.
84. Maresso, A. W., Garufi, G., and Schneewind, O. 2008. Bacillus anthracis secretes proteins that mediate heme acquisition from hemoglobin. PLoS Pathog, 4, e1000132.
85. Matz, L. L., Beaman, T. C., and Gerhardt, P. 1970. Chemical composition of exosporium from spores of Bacillus cereus. J Bacteriol, 101, 196 - 201.
86. McKevitt, M. T., Bryant, K. M., Shakir, S. M. et al. 2007. Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections. Infect Immun, 75, 5726 - 5734.
87. Melnyk, R. A. and Collier, R. J. 2006. A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation. Proc Natl Acad Sci U S A, 103, 9802 - 9807.
88. Mesnage, S., Tosi-Couture, E., Gounon, P. et al. 1998. The capsule and S-layer: two independent and yet compatible macromolecular structures in Bacillus anthracis. J Bacteriol, 180, 52 - 58.
89. Mignot, T., Mock, M., Robichon, D. et al. 2001. The incompatibility between the PlcR-and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol Microbiol, 42, 1189 - 1198.
90. Miyoshi, S. and Shinoda, S. 2000. Microbial metalloproteases and pathogenesis. Microbes Infect, 2, 91 - 98.
91. Moayeri, M., Haines, D., Young, H. A., and Leppla, S. H. 2003. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest, 112, 670 - 682.
92. Mock, M. and Fouet, A. 2001. Anthrax. Annu Rev Microbiol, 55, 647 - 671.
93. Nakouzi, A., Rivera, J., Rest, R. F., and Casadevall, A. 2008. Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis. BMC Microbiol, 8, 159.
94. Nassif, X. and Sansonetti, P. J. 1986. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun, 54, 603 - 608.
95. Nishihara, T., Takubo, Y., Kawamata, E. et al. 1989. Role of outer coat in resistance of Bacillus megaterium spore. J Biochem, 106, 270 - 273.
96. Oliva, C. R., Swiecki, M. K., Griguer, C. E. et al. 2008. The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc Natl Acad Sci U S A, 105, 1261 - 1266.
97. Paccani, S. R., Tonello, F., Ghittoni, R. et al. 2005. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med, 201, 325 - 331.
98. Passalacqua, K. D., Bergman, N. H., Herring-Palmer, A., and Hanna, P. 2006. The superoxide dismutases of Bacillus anthracis do not cooperatively protect against endogenous superoxide stress. J Bacteriol, 188, 3837 - 3848.
99. Patti, J. M., Jonsson, H., Guss, B. et al. 1992. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem, 267, 4766 - 4772.
100. Pellizzari, R., Guidi-Rontani, C., Vitale, G. et al. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett, 462, 199 - 204.
101. Pezard, C., Berche, P., and Mock, M. 1991 Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun, 59, 3472 - 3477.
102. Pickering, A. K., Osorio, M., Lee, G. M. et al. 2004. Cytokine response to infection with Bacillus anthracis spores. Infect Immun, 72, 6382 - 6389.
103. Pitt, M. L., Little, S., Ivins, B. E. et al. 1999. In vitro correlate of immunity in an animal model of inhalational anthrax. J Appl Microbiol, 87, 304.
104. Popov, S. G., Popova, T. G., Hopkins, S. et al. 2005. Effective antiprotease-antibiotic treatment of experimental anthrax. BMC Infect Dis, 5, 25.
105. Portnoy, D. A., Auerbuch, V., and Glomski, I. J. 2002. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J Cell Biol, 158, 409 - 414.
106. Read, T. D., Peterson, S. N., Tourasse, N. et al. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature, 423, 81 - 86.
107. Redmond, C., Baillie, L. W., Hibbs, S. et al. 2004 Identifi cation of proteins in the exosporium of Bacillus anthracis. Microbiology, 150, 355 - 363.
108. Rich, R. L., Kreikemeyer, B., Owens, R. T. et al. 1999. Ace is a collagen-binding MSCRAMM from Enterococcus faecalis. J Biol Chem, 274, 26939 - 26945.
109. Richter, S., Anderson, V. J., Garufi, G. et al. 2008. Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidin. Mol Microbiol, 21, 404 - 420.
110. Ross, J. M. 1957. The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol, 73, 485 - 494.
111. Russell, B. H., Vasan, R., Keene, D. R., and Xu, Y. 2007. Bacillus anthracis internalization by human fi broblasts and epithelial cells. Cell Microbiol, doi:10.1111/ j.1462-5822.2006.00869.x.
112. Russell, B. H., Vasan, R., Keene, D. R. et al. 2008. Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells. Cell Microbiol, 10, 945 - 957.
113. Ruthel, G., Ribot, W. J., Bavari, S., and Hoover, T. A. 2004. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis, 189, 1313 - 1316.
114. Sanz, P., Teel, L. D., Alem, F. et al. 2008. Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infect Immun, 76, 1036 - 1047.
115. Schneerson, R., Kubler-Kielb, J., Liu, T. Y. et al. 2003. Poly (gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc Natl Acad Sci U S A, 100, 8945 - 8950.
116. Scobie, H. M., Rainey, G. J., Bradley, K. A., and Young, J. A. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A, 100, 5170 - 5174.
117. Sirisanthana, T. and Brown, A. E. 2002. Anthrax of the gastrointestinal tract. Emerg Infect Di s, 8, 9 - 651.
118. Skaar, E. P., Gaspar, A. H., and Schneewind, O. 2004. IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. J Biol Chem, 279, 436 - 443.
119. Skaar, E. P., Gaspar, A. H., and Schneewind, O. 2006. Bacillus anthracis IsdG, a heme-degrading monooxygenase. J Bacteriol, 188, 1071 - 1080.
120. Skurnik, M., El Tahir, Y., Saarinen, M. et al. 1994. YadA mediates specifi c binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect Immun, 62, 1252 - 1261.
121. Spencer, R. C. 2003. Bacillus anthracis. J Clin Pathol, 56, 182 - 187.
122. Steichen, C., Chen, P., Kearney, J. F., and Turnbough, C. L. Jr. 2003. Identifi cation of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J Bacteriol, 185, 1903 - 1910.
123. Steichen, C. T., Kearney, J. F., and Turnbough, C. L. Jr. 2007. Non-uniform assembly of the Bacillus anthracis exosporium and a bottle cap model for spore germination and outgrowth. Mol Microbiol, 64, 359 - 367.
124. Sylvestre, P., Couture-Tosi, E., and Mock, M. 2002. A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol, 45, 169 - 178.
125. Sylvestre, P., Couture-Tosi, E., and Mock, M. 2003. Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium fi lament length. J Bacteriol, 185, 1555 - 1563.
126. Tessier, J., Green, C., Padgett, D. et al. 2007. Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Infect Immun, 75, 1895 - 1903.
127. Thomas, R. J., Webber, D., Sellors, W. et al. 2008. Characterization and deposition of respirable large-and small-particle bioaerosols. Appl Environ Microbiol, 74, 6437 - 6443.
128. Titball, R. W., Turnbull, P. C., and Hutson, R. A. 1991. The monitoring and detection of Bacillus anthracis in the environment. Soc Appl Bacteriol Symp Ser, 20, 9S-18S.
129. Tournier, J. N., Quesnel-Hellmann, A., Mathieu, J. et al. 2005. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol, 174, 4934 - 4941.
130. Turnbull, P. C. 1991. Anthrax vaccines: past, present and future. Vaccine, 9, 533 - 539.
131. Van Sorge, N. M., Ebrahimi, C. M., Mcgillivray, S. M. et al. 2008. Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS ONE, 3, e2964.
132. Warfel, J. M., Steele, A. D., and D ' Agnillo, F. 2005. Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol, 166, 1871 - 1881.
133. Watters, J. W., Dewar, K., Lehoczky, J. et al. 2001. Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Curr Biol, 11, 1503 - 1511.
134. Weaver, J., Kang, T. J., Raines, K. W. et al. 2007. Protective role of Bacillus anthracis exosporium in macrophage-mediated killing by nitric oxide. Infect Immun, 75, 3894 - 3901.
135. Weiner, M. A. and Hanna, P. C. 2003. Macrophage-mediated germination of Bacillus anthracis endospores requires the gerH operon. Infect Immun, 71, 3954 - 3959.
136. Welkos, S. L. 1991. Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis. Microb Pathog, 10, 183 - 198.
137. WHO. 2008. Anthrax in Humans and Animals. Geneva: World Health Organization.
138. Xu, Y., Liang, X., Chen, Y. et al. 2004. Identifi cation and biochemical characterization of two novel collagen binding MSCRAMMs of Bacillus anthracis. J Biol Chem, 279, 51760 - 51768.
139. Xu, L., Fang, H., and Frucht, D. M. 2008. Anthrax lethal toxin increases superoxide production in murine neutrophils via differential effects on MAPK signaling pathways. J Immunol, 180, 4139 - 4147.
140. Young, J. A. and Collier, R. J. 2007. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. A nnu Rev Biochem, 76, 243 - 265.
141. Zaucha, G. M., Pitt, L. M., Estep, J. et al. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch Pathol Lab Med, 122, 982 - 992.
142. Zenewicz, L. A., Wei, Z., Goldfi ne, H., and Shen, H. 2005. Phosphatidylinositol-specifi c phospholipase C of Bacillus anthracis down-modulates the immune response. J Immunol, 174, 8011 - 8016.
143. Zwartouw, H. T. and Smith, H. 1956. Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity. Biochem J, 63, 437 - 442.